3SBIO INC.

1530
Delayed Hong Kong Stock Exchange - 03:08 2022-11-25 am EST
8.080 HKD  0.00%

Turn to zoom
Prev.8.08000000
Open8.00000000
High8.09000000
Low7.93000000
Volume14 286 500
Latest news
08/24
08/24
08/24
07/28
Chart 3SBIO INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance8,478,908,51
Spread/Res.-4,6%-9,2%-5,1%
Spread/Supp.17%33%23%
Support6,886,076,56
Financials
Sales 2022 6 719 M 937 M 937 M
Net income 2022 1 724 M 240 M 240 M
Net cash 2022 2 195 M 306 M 306 M
P/E ratio 2022 10,9x
Yield 2022 0,96%
Capitalization 18 077 M 2 521 M 2 521 M
EV / Sales 2022 2,36x
EV / Sales 2023 2,00x
Nbr of Employees 5 160
Free-Float 72,0%
Company
3SBio Inc. is an investment holding company mainly engaged in the the development, production, marketing and sale of pharmaceutical products. The Company’s main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)αinhibitor products and recombinant...
Sector :
Biopharmaceuticals
Calendar :
2023-03-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 7,41 CNY
Average target price 6,45 CNY
Spread / Average Target -12,9%